Jianming M. Xu
No. 8 East Street
Fengtai, 100071, China
Fengtai, 100071, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 319 publications
Benefits of CO2 Fertilization on Global Grassland Nitrogen Cycles.
Journal: Environmental science & technology
Published: March 12, 2026
Expansion of IL-2-independent tumor-infiltrating lymphocytes through a feeder-free process: a preclinical study for solid tumors.
Journal: Cancer biology & medicine
Published: March 06, 2026
First-line immunotherapy for advanced HER2-negative gastric cancer: differences between Asian and non-Asian patients.
Journal: Cancer biology & medicine
Published: March 02, 2026
Tunable nanoarchitectonics of porous biochar through sequential calcium and potassium salt activation for high-efficiency removal of emerging pollutants.
Journal: Bioresource technology
Published: February 03, 2026
Anti-PD-1 monoclonal antibody suppresses hepatitis B virus in patients with hepatocellular carcinoma.
Journal: Chinese medical journal
Published: November 11, 2025
Anbenitamab in previously treated HER2-positive gastric cancer (KC-WISE): prespecified interim analysis of a randomized, phase III clinical trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 05, 2025
Comparative effectiveness of first-line taxane-platinum versus fluorouracil-platinum chemotherapy in advanced esophageal squamous cell carcinoma: a propensity score-matched real-world study.
Journal: Therapeutic advances in medical oncology
Published: October 08, 2025
Current progress in neoantigen-based dendritic cell vaccines for solid tumors.
Journal: Cancer biology & medicine
Published: September 30, 2025
Enhanced immobilization of cadmium, lead, and antimony with improved soil fertility using sulfate-reducing bacteria@nano zero-valent iron-modified biochar: coupled chemisorption and microbial mechanisms.
Journal: Frontiers in microbiology
Published: September 25, 2025
A novel fully human anti-ROR1 antibody PBA-0405 optimized for ADCC, induces potent anti-tumor activity against both solid and hematological malignancies.
Journal: Frontiers in immunology
Published: September 23, 2025
Last Updated: 09/26/2026